| CAS NO: | 59831-65-1 |
| 包装 | 价格(元) |
| 10 mM * 1 mL in DMSO | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 200mg | 电议 |
| 500mg | 电议 |
| 生物活性 | Halopemide is a potentphospholipaseD (PLD)inhibitor, withIC50s of 220 and 310 nM for human PLD1 and PLD2, respectively. Halopemid is adopamine receptorsantagonist, and acts a psychotropic agent[1][2]. | ||||||||||||||||
| IC50& Target[1][2] |
| ||||||||||||||||
| 体外研究 (In Vitro) | Halopemide (1-2 μM; 21 day) affects calcification in transdifferentiated MOVAS cells[3]. | ||||||||||||||||
| 体内研究 (In Vivo) | Halopemide (10 mg/kg; p.o.) induces dyskinesias in the majority of monkeys tested[2]. | ||||||||||||||||
| 分子量 | 416.88 | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| Formula | C21H22ClFN4O2 | ||||||||||||||||
| CAS 号 | 59831-65-1 | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 |
| ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 41.67 mg/mL(99.96 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
